Clinically, M-CSF and its receptor, Colony Stimulating Factor-1 Receptor (CSF1R), were elevated in breast cancer patients with local invasion or metastasis compared to those without tumor spread, and their expression predicted poor survival [149,150]. Here, CSF1 is linked to neoplasm.